Cancer Statistics, 2007

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M. J.·2007·CA: A Cancer Journal for Clinicians

Cited by (1,016)

Items 501–600 of 1,016

  1. Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes
    Neelima Denduluri, Jennifer A. Low, James J. Lee, Arlene W. Berman, Janice Maria Walshe, Ujala Vatas, Catherine K. Chow, Seth M. Steinberg, Sherry X. Yang, Sandra M. Swain · 2007 · Journal of Clinical Oncology
  2. Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
    Zhimin Tong, Ajaikumar Bahulayan Kunnumakkara, Huamin Wang, Yoichi Matsuo, Parmeswaran Diagaradjane, Kuzhuvelil B. Harikumar, Vijaya Ramachandran, Bokyung Sung, Arup Chakraborty, Robert S. Bresalier et al. · 2008 · Cancer Research
  3. An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma
    Ian D. Davis, Birte K. Skrumsager, Jonathan Simon Cebon, Theo Nicholaou, John W. Barlow, Niels Peter Hundahl Møller, Kresten Skak, Dorthe Lundsgaard, Klaus Stensgaard Frederiksen, Peter Thygesen et al. · 2007 · Clinical Cancer Research
  4. A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice
    Naghma Khan, Mohammad Asim, Farrukh Afaq, Mohammad Issam Abu Zaid, Hasan Mukhtar · 2008 · Cancer Research
  5. miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer
    Michael R. Epis, Keith Michael Giles, Andrew J Barker, Tulene S. Kendrick, Peter J. Leedman · 2009 · Journal of Biological Chemistry
  6. Transumbilical single‐port laparoscopic partial nephrectomy
    Monish Aron, David Canes, Mihir M. Desai, Georges‐Pascal Haber, Jihad H Kaouk, Inderbir Singh Gill · 2008 · British Journal of Urology
  7. Circulating tumor cells in metastatic breast cancer
    Shaheenah S. Dawood, Kristine R. Broglio, Vicente Valero, James Reuben, Beverly Carol Handy, Rabiul Islam, Summer A. Jackson, Gabriel N. Hortobágyi, Herbert A. Fritsche, Massimo Cristofanilli · 2008 · Cancer
  8. Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
    Jamin A. Willoughby, Shyam N. Sundar, Mark Cheung, Antony S. Tin, Jaime F. Modiano, Gary L. Firestone · 2008 · Journal of Biological Chemistry
  9. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
    James R. Cerhan, Stephen Maxted Ansell, Zachary S. Fredericksen, Neil E. Kay, Mark Liebow, Timothy G. Call, Ahmet Doǧan, Julie M. Cunningham, Alice H. Wang, Wen Liu‐Mares et al. · 2007 · Blood
  10. Applications of transrectal ultrasound in prostate cancer
    C J Harvey, J. Pilcher, Jonathan Richenberg, Uday Patel, Ferdinand Frauscher · 2012 · British Journal of Radiology
  11. Cancer incidence in the multicenter aids cohort study before and during the HAART era
    Eric C. Seaberg, Dorothy J. Wiley, Otoniel Martı́nez-Maza, Joan Sander Chmiel, Lawrence Kingsley, Yi‐Wei Tang, Joseph B. Margolick, Lisa P. Jacobson · 2010 · Cancer
  12. The functional significance of microRNA-145 in prostate cancer
    Mohd Saif Zaman, Y Chen, G Deng, Varahram Shahryari, Seong O Suh, Sharanjot Saini, S Majid, J Liu, Gaurav Khatri, Yuichiro Tanaka et al. · 2010 · British Journal of Cancer
  13. Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
    Qiongfang Zhang, Wenwei Yin, Yang Xia, Ya-Yang Yi, Qiufeng He, Xing Wang, Hong Ren, Dazhi Zhang · 2016 · Cellular and Molecular Immunology
  14. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Kang Qin, Helei Hou, Liang Yu, Xiaochun Zhang · 2020 · BMC Cancer
  15. Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular Carcinoma
    Andrew Xiuxuan Zhu, Nagaraj-Setty Holalkere, Alona Muzikansky, Kerry E Horgan, Dushyant V. Sahani · 2008 · The Oncologist
  16. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
    Ram Eitan, Michal Kushnir, Gila Lithwick‐Yanai, M David, Moshe Hoshen, Marek Glezerman, Moshe Hod, Gad Sabah, Shai Rosenwald, Hanoch Levavi · 2009 · Gynecologic Oncology
  17. Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice
    Rana Pratap Singh, Komal Raina, Girish D. Sharma, Rajesh Agarwal · 2008 · Clinical Cancer Research
  18. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
    Zhao, Mei, Gao, Feng-Hou, Wang, Jiong-Yi, Liu, Feng, Yuan, Hai-Hua, Zhang, Wen-Ying, Jiang, Bin · 2011 · Lung Cancer
  19. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century
    Igor Matushansky, Elizabeth Charytonowicz, Joslyn E. Mills, Sara Siddiqi, Todd Hricik, Carlos Cordon‐Cardo · 2009 · Expert Review of Anticancer Therapy
  20. Lupeol: Connotations for chemoprevention
    Pranav Kumar Chaturvedi, Kulpreet Bhui, Yogeshwer Shukla · 2008 · Cancer Letters
  21. Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers
    Costa, Daniel B., Kobayashi, Susumu, Tenen, Daniel G., Huberman, Mark S. · 2007 · Lung Cancer
  22. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR
    Monika Jung, Azizbek Ramankulov, Jan Roigas, Manfred Johannsen, Martin Ringsdorf, Glen Kristiansen, Klaus Jung · 2007 · BMC Molecular Biology
  23. SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells
    Si Chen, Yingxi Xu, Yanan Chen, Xuefei Li, Wenjun Mou, Lina Wang, Yanhua Liu, Ralph A. Reisfeld, Rong Xiang, Dan Lv et al. · 2012 · PLoS ONE
  24. Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients
    Michael C. Cheung, Kara Hamilton, Recinda Sherman, Margaret M. Byrne, Dao M. Nguyen, Dido Franceschi, Leonidas G. Koniaris · 2008 · Annals of Surgical Oncology
  25. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer
    Jason H. Smouse, Edmund S. Cibas, Pasi Antero Janne, Victoria A. Joshi, Kelly H. Zou, Neal Ian Lindeman · 2009 · Cancer Cytopathology
  26. Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma
    Naomi Y. Jiang, Bruce A. Woda, Barbara F. Banner, Giles Francis Whalen, Karen Dresser, Di Lü · 2008 · Cancer Epidemiology Biomarkers & Prevention
  27. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis
    Mohamed A. Bedaiwy, Ahmed M Abou-Setta, Nina Desai, William W. Hurd, David C Starks, Sherif A. El‐Nashar, Hesham Gaber Al-Inany, Tommaso Falcone · 2010 · Fertility and Sterility
  28. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation
    Ana Maria Sanchez, Sophie Malagarie‐Cazenave, Nuria Olea, Diana Vara‐Ciruelos, Antonio Chiloeches, Inés Díaz‐Laviada · 2007 · APOPTOSIS
  29. Characterizing DNA methylation patterns in pancreatic cancer genome
    Aik Choon Tan, Antonio Jimeno, Steven Hsesheng Lin, Jenna Wheelhouse, Fonda Chan, Anna Solomon, N.V. Rajeshkumar, Belén Rubio‐Viqueira, Manuel M. Hidalgo · 2009 · Molecular Oncology
  30. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
    Paul P. Anglim, Todd A. Alonzo, Ite A. Laird‐Offringa · 2008 · Molecular Cancer
  31. Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer
    Simon J. Crabb, Demetris Patsios, Eric E. Sauerbrei, Peter M. Ellis, Andrew Arnold, Glenwood D. Goss, Natasha B. Leighl, Frances A. Shepherd, Jean Powers, Lesley Seymour et al. · 2008 · Journal of Clinical Oncology
  32. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
    Vassilis Golfinopoulos, Georgia Salanti, Nicholas A. Pavlidis, John P. A. Ioannidis · 2007 · The Lancet Oncology
  33. Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas
    Tobias Klatte, Jean‐Jacques Patard, Michela de Martino, Karim Bensalah, Grégory Verhoest, Alexandre DE LA TAILLE, Clement-Claude C Abbou, Ernst Peter Allhoff, Giuseppe Carrieri, Stephen Boyd Riggs et al. · 2008 · The Journal of Urology
  34. Scanometric MicroRNA Array Profiling of Prostate Cancer Markers Using Spherical Nucleic Acid–Gold Nanoparticle Conjugates
    Ali H. Alhasan, Dae Young Kim, Weston L. Daniel, Erin Watson, Joshua J. Meeks, Colby Shad Thaxton, Chad Alexander Mirkin · 2012 · Analytical Chemistry
  35. Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
    Laleh Golkar Melstrom, Mohammad Reza Salabat, Xian-Zhong Ding, Benjamin M. Milam, Matthew J. Strouch, Jill C. Pelling, David J. Bentrem · 2008 · Pancreas
  36. Proton therapy in chordoma of the base of the skull: a systematic review
    Maurizio Amichetti, Marco Cianchetti, Dante Amelio, Riccardo Maurizi Enrici, Giuseppe Caracciolo Minniti · 2009 · Neurosurgical Review
  37. Prostate cancer in elderly men.
    Anton Stangelberger, Matthias Waldert, Bob Djavan · 2008 · Europe PMC (PubMed Central)
  38. Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238
    Gregory Loewen, Dorothy M. Watson, Leslie J. Kohman, James E. Herndon, Hani Shennib, Kemp H. Kernstine, Jemi Olak, Martin Jeffery Mador, David H. Harpole, David J. Sugarbaker et al. · 2007 · Journal of Thoracic Oncology
  39. ABCG2: the key to chemoresistance in cancer stem cells?
    Yi An, Weg M. Ongkeko · 2009 · Expert Opinion on Drug Metabolism & Toxicology
  40. Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer
    Rui Li, Zhongliang Hu, Shi‐Yong Sun, Zhuo G. Chen, Taofeek Kunle Owonikoko, Gabriel Sica, Suresh S. Ramalingam, Walter John Curran, Fadlo Raja Khuri, Xingming Deng · 2013 · Molecular Cancer Therapeutics
  41. The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?
    Marco Roscigno, Shahrokh François Shariat, Vitaly Margulis, Pierre I. Karakiewicz, Mesut Remzi A, Eiji Kikuchi, Richard E. Zigeuner, Alon Z. Weizer, Arthur I. Sagalowsky, Karim Bensalah et al. · 2009 · European Urology
  42. Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung Carcinomas
    Nicola Amodio, Marianna Scrima, Lucia Palaia, Ali Naeem Salman, Alfina Quintiero, Renato Franco, Gerardo Botti, Pino Pirozzi, Gaetano Rocco, Nicla De Rosa et al. · 2010 · American Journal Of Pathology
  43. Nanotechnology for breast cancer therapy
    Takemi Tanaka, Paolo Decuzzi, Massimo Cristofanilli, Jason H. Sakamoto, Ennio Tasciotti, Fredika M. Robertson, Mauro Ferrari B · 2008 · Biomedical Microdevices
  44. Adjuvant Chemotherapy for Breast Cancer: Effects on Cerebral White Matter Seen in Diffusion Tensor Imaging
    Jame Abraham, Marc W. Haut, María Teresa Cabero Morán, Shannon Filburn, Susan Lemiuex, Hiroto Kuwabara · 2008 · Clinical Breast Cancer
  45. Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
    Girish Sardana, Barry L. Dowell, Eleftherios P. Diamandis · 2008 · Clinical Chemistry
  46. Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Lisa K. Dunnwald, Julie R. Gralow, Georgiana Kehr Ellis, Robert B. Livingston, Hannah M. Linden, Jennifer M. Specht, Robert K. Doot, Thomas J. Lawton, William Eric Barlow, Brenda F. Kurland et al. · 2008 · Journal of Clinical Oncology
  47. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis
    Lantao Chen, Shidong Xu, Hai Xu, Jinfeng Zhang, Jinfeng Ning, Sheng-fa Wang · 2011 · Medical Oncology
  48. 1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer
    Amy L. Vāvere, Steven J. Kridel, Frances B. Wheeler, Jason Stuart Lewis · 2008 · Journal of Nuclear Medicine
  49. let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression
    Jérôme Torrisani, Barbara Bournet, M. Chalret du Rieu, Michèle Bouisson, Anny Souque, Jean R. Escourrou, Louis Buscail, Pierre Cordelier · 2009 · Human Gene Therapy
  50. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
    Marco Roscigno, Maurizio A. Brausi, Axel Heidenreich, Yair Lotan, Vitaly Margulis, Shahrokh François Shariat, Hendrik Van Poppel, Richard E. Zigeuner · 2011 · European Urology
  51. Protective Effects of Garlic and Silymarin on NDEA-Induced Rats Hepatotoxicity
    Sabry Shaarawy, Amany A. Tohamy, Saad M. El‐Gendy, Zakaria Y. Abd Elmageed, Abeer A. Bahnasy, Maha Salah Eldin Mohamed, Emad H. Kandil, Khalid Matrougui · 2009 · International Journal of Biological Sciences
  52. Therapeutic Targeting of ATP7B in Ovarian Carcinoma
    Lingegowda Selanere Mangala, Vesna Zuzel, Rosemarie E. Schmandt, Erik S LeShane, Jyotsna B. Halder, Guillermo N. Armaiz-Peña, Whitney A. Spannuth, Takemi Tanaka, Mian M.K. Shahzad, Yvonne Gail Lin et al. · 2009 · Clinical Cancer Research
  53. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
    Michael J. Hallek · 2013 · American Journal of Hematology
  54. Contemporary Evaluation of the D’Amico Risk Classification of Prostate Cancer
    David J. Hernandez, Matthew E. Nielsen, Misop Han, Alan Wayne Partin · 2007 · Urology
  55. Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer
    Karl Y. Bilimoria, Marina Talamonti, Stephen Francis Sener, Malcolm M. Bilimoria, Andrew K. Stewart, David Porter Winchester, Clifford Y. Ko, David J. Bentrem · 2008 · Journal of the American College of Surgeons
  56. Cyclooxygenase-2 in oncogenesis
    Maria Teresa Rizzo · 2010 · Clinica Chimica Acta
  57. Functional significance of VEGFR‐2 on ovarian cancer cells
    Whitney A. Spannuth, Alpa Manchandia Nick, Nicholas B. Jennings, Guillermo N. Armaiz-Peña, Lingegowda Selanere Mangala, Christopher G. Danes, Yvonne Gail Lin, William M. Merritt, Premal H. Thaker, Aparna A. Kamat et al. · 2008 · International Journal of Cancer
  58. Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer
    Oleg Tatarov, Thomas J. Mitchell, Morag M. Seywright, Hing Y. Leung, Valerie G. Brunton, Joanne Edwards · 2009 · Clinical Cancer Research
  59. Histopathology of Ovarian Tumors in Laying Hens
    Animesh Barua, Pincas Bitterman, Jacques S. Abramowicz, Angela L. Dirks, Janice M. Bahr, Dale Buchanan Hales, Michael J. Bradaric, Seby Louis Edassery, Jacob Rotmensch, Judith L. Luborsky · 2009 · International Journal of Gynecological Cancer
  60. Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
    Junko Yokokawa, Vittore Cereda, Cinzia Remondo, James L. Gulley, Philip Martin Arlen, Jeffrey Schlom, Kwong Yok Tsang · 2008 · Clinical Cancer Research
  61. Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection
    Xin‐Rong Yang, Yang Xu, Guo‐Ming Shi, Jia Fan, Jian Zhou, Yuan Ji, Hui‐Chuan Sun, Shuang–Jian Qiu, Bing Yu, Qiang Gao et al. · 2008 · Clinical Cancer Research
  62. The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1 −/− murine model of ovarian cancer
    Jing Huang, Lei Wang, Zhongyi Cong, Zohreh Amoozgar, Evgeny Kiner, Deyin Xing, Sandra Oršulić, Ursula A. Matulonis, Michael S. Goldberg · 2015 · Biochemical and Biophysical Research Communications
  63. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
    Margaret Gil, Marcin P. Komorowski, Mukund Seshadri, Hanna Rokita, AJ Robert McGray, Mateusz Opyrchal, Kunle O. Odunsi, Danuta Kozbor · 2014 · The Journal of Immunology
  64. What Are Terminally Ill Cancer Patients Told About Their Expected Deaths? A Study of Cancer Physicians’ Self-Reports of Prognosis Disclosure
    Christopher K. Daugherty, Fay J. Hlubocky · 2008 · Journal of Clinical Oncology
  65. The impact of early detection and intervention of breast cancer‐related lymphedema: a systematic review
    Chirag Shah, Douglas W. Arthur, David E. Wazer, Atif J. Khan, Sheila Hedden Ridner, Frank A. Vicini · 2016 · Cancer Medicine
  66. Copy number alterations in pancreatic cancer identify recurrentPAK4amplification
    Shuaili Chen, Theresa Auletta, Ostap Dovirak, Christina Hutter, Karen Kuntz, Samyra El‐ftesi, Jude Kendall, Haiyong Han, Daniel D. Von Hoff, Raheela Ashfaq et al. · 2008 · Cancer Biology & Therapy
  67. Mapping cancer mortality‐to‐incidence ratios to illustrate racial and sex disparities in a high‐risk population
    James R. Hébert, Virginie Daguisé, Deborah M. Hurley, Rebecca C. Wilkerson, Catishia Mosley, Swann Arp Adams, Robin C. Puett, James B. Burch, Susan E. Steck, Susan W Bolick-Aldrich · 2009 · Cancer
  68. Religiosity, Spirituality, and Cancer Fatalism Beliefs on Delay in Breast Cancer Diagnosis in African American Women
    Mary Magee Gullatte, Otis W. Brawley, Anita Yeomans Kinney, Barbara D. Powe, Kathi H. Mooney · 2009 · Journal of Religion and Health
  69. Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53
    Shakti Ranjan Satapathy, Purusottam Mohapatra, Ranjan Preet, Dipon Das, Biplab Sarkar, Tathagata Choudhuri, Michael D. Wyatt, Chanakya Nath Kundu · 2013 · Nanomedicine
  70. Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation
    Sara Ann Byron, Michael G. Gartside, Candice L. Wellens, Mary Ann Mallon, Jack B. Keenan, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock · 2008 · Cancer Research
  71. The critical role of the bone microenvironment in cancer metastases
    Sandra Casimiro, Theresa A. Guise, John M. Chirgwin · 2009 · Molecular and Cellular Endocrinology
  72. Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity
    Vera Hirsh, Pierre P Major, Allan Lipton, Richard J. Cook, Corey Jay Langer, Matthew Raymond Smith, Janet Elizabeth Brown, Robert Edward Coleman · 2008 · Journal of Thoracic Oncology
  73. Overexpression of leucine‐rich repeat‐containing G protein‐coupled receptor 5 in colorectal cancer
    Hiroshi Uchida, Ken Yamazaki, Mariko Fukuma, Taketo Yamada, Tetsu Hayashida, Hirotoshi Hasegawa, Masaki Kitajima, Yuko Kitagawa, Michiie Sakamoto · 2010 · Cancer Science
  74. Physical activity, sedentary behavior, and endometrial cancer risk in the NIH‐AARP Diet and Health Study
    Gretchen L. Gierach, Shih‐Chen Chang, Louise Annette Brinton, James Vincent Lacey, Albert R. Hollenbeck, Arthur G. Schatzkin, Michael Fred Leitzmann · 2008 · International Journal of Cancer
  75. Vitagenes, cellular stress response, and acetylcarnitine: Relevance to hormesis
    Vittorio Calabrese, Carolin Cornelius, Albena T. Dinkova‐Kostova, Edward J. Calabrese · 2009 · BioFactors
  76. Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer
    Robyn L. Prueitt, Ming Yi, Robert S. Hudson, Tiffany A. Wallace, Tiffany M. Howe, Harris G. Yfantis, Dong Hoon Lee, Robert M. Stephens, Chang‐Gong Liu, George Adrian Calin et al. · 2008 · The Prostate
  77. p53 cooperates berberine‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo
    Santosh K. Katiyar, Syed Musthapa Meeran, Nandan Katiyar, Suhail Akhtar · 2008 · Molecular Carcinogenesis
  78. Determination of DNA and RNA Methylation in Circulating Tumor Cells by Mass Spectrometry
    Wei Huang, Chu-Bo Qi, Song-Wei Lv, Min Xie, Yu‐Qi Feng, Wei‐Hua Huang, Bi‐Feng Yuan · 2015 · Analytical Chemistry
  79. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
    Michael P. Porter, Matthew C. Kerrigan, Bonnie M.K. Donato, Scott David Ramsey · 2009 · Urologic Oncology Seminars and Original Investigations
  80. Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer
    Akihiko Yoshizawa, Junya Fukuoka, Shigeki Shimizu, Konstantin Shilo, Teri J. Franks, Stephen M. Hewitt, Takeshi Fujii, Carlos Cordon‐Cardo, Jin Jen, William David Travis · 2009 · Clinical Cancer Research
  81. Synthesis of fluorescent nitrogen-doped carbon dots from dried shrimps for cell imaging and boldine drug delivery system
    Stephanie L. D’souza, Balaji Deshmukh, Jigna R. Bhamore, Karuna A. Rawat, Nibedita Lenka, Suresh Kumar Kailasa · 2016 · RSC Advances
  82. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF
    Hoffmann, Andreas-Claudius, Mori, Ryutaro, Vallbohmer, Daniel, Brabender, Jan, Klein, Ellen, Drebber, Uta, Baldus, Stephan E., Cooc, Janine, Azuma, Mizutomo, Metzger, Ralf et al. · 2008 · Neoplasia
  83. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide
    Catherine E. Jansen, Marylin J. Dodd, Christine A. Miaskowski, Glenna A. Dowling, Joel H. Kramer · 2008 · Psycho-Oncology
  84. Survival after hepatic resection of colorectal cancer metastases
    Douglas J. Robertson, Thérèse A. Stukel, Daniel J. Gottlieb, Jason Murray Sutherland, Elliott S. Fisher · 2009 · Cancer
  85. Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
    Yukino Kimura, Jun Tsukada, Takeshi Tomoda, Hidenori Takahashi, Kazuhiro Imai, Shimamura Kanae, Makoto Sunamura, Yoshikazu Yonemitsu, Shigetaka Shimodaira, Shigeo Koido et al. · 2011 · Pancreas
  86. Profiling gastrin‐releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates
    Marc Beer, M. Montani, Josefine Gerhardt, Peter Johannes Wild, Thomas F. Hany, Thomas Hermanns, Michael Müntener, Glen Kristiansen · 2011 · The Prostate
  87. Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
    Eric Yang, Adrienne Ann Boire, Anika Agarwal, Nga Nguyen, Katie O’Callaghan, Powen Tu, Athan Kuliopulos, Lidija Covic · 2009 · Cancer Research
  88. Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation
    Steven J. Heitman, Robert J. Hilsden, Flora Au, Scot D. Dowden, Braden Manns · 2010 · PLoS Medicine
  89. Synchronous colorectal liver metastasis: A network meta‐analysis review comparing classical, combined, and liver‐first surgical strategies
    Michael Eamon Kelly, Gaya Spolverato, Giao N Le, Michail N. Mavros, Frank Doyle, Timothy Michael Pawlik, Des C. Winter · 2014 · Journal of Surgical Oncology
  90. Estrogen and progesterone receptors: from molecular structures to clinical targets
    Stephan Ellmann, Heinrich Sticht, Falk Clemens Thiel, Matthias W. Beckmann, Reiner Strick, Pamela L. Strissel · 2009 · Cellular and Molecular Life Sciences
  91. Serous ovarian carcinoma patients with high alpha‐folate receptor had reducing survival and cytotoxic chemo‐response
    Yu‐Li Chen, Ming‐Cheng Chang, Chia‐Yen Huang, Ying‐Cheng Chiang, Han-Wei Lin, Chi‐An Chen, Chang‐Yao Hsieh, Wen‐Fang Cheng · 2011 · Molecular Oncology
  92. Performance of integrated FDG–PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG–PET/non-contrast-enhanced CT and enhanced CT
    Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Domeki, Yasushi Kaji, Ichio Fukasawa, Noriyuki Inaba, Narufumi Suganuma, Kazuro Sugimura · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  93. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
    M. Robyn Andersen, Barbara Ann Goff, Kimberly Anne Lowe, Nathalie Scholler, Lindsay A. Bergan, Charles W. Drescher, Pamela J. Paley, Nicole D. Urban · 2009 · Gynecologic Oncology
  94. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
    Zhi-Yue Rao, Mu-Yan Cai, Guo-Fen Yang, Li-Ru He, Shi‐Juan Mai, Wen‐Feng Hua, Yi-Ji Liao, Hai-Xia Deng, Yangchao Chen, Xin‐Yuan Guan et al. · 2010 · Carcinogenesis
  95. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
    Jing Shi, Demao Yao, Wei Liu, Na Wang, Hongjun Lv, Guanjun Zhang, Meiju Ji, Xu Li, Nongyue He, Bingyin Shi et al. · 2012 · BMC Cancer
  96. Factors in Quality Care--The Case of Follow-Up to Abnormal Cancer Screening Tests--Problems in the Steps and Interfaces of Care
    Zapka, J., Taplin, S. H., Anhang Price, R., Cranos, C., Yabroff, R. · 2010 · JNCI Monographs
  97. The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
    Bo O. Zhou, Chaoyang Sun, Jia Ming Huang, Meng Xia, Ensong Guo, Na Li, Hao Lü, Wanying Shan, Yifan Wu, Yuan Li et al. · 2019 · Scientific Reports
  98. A Matter Of Race: Early-Versus Late-Stage Cancer Diagnosis
    Beth A Virnig, Nancy Noel Baxter, Elizabeth Butzer Habermann, Roger D Feldman, Cathy J. Bradley · 2009 · Health Affairs
  99. Resveratrol inhibits glucose metabolism in human ovarian cancer cells
    Angela S. Kueck, Anthony W. Opipari, Kent A. Griffith, Lijun Tan, Milheon Choi, Jennifer T. Huang, Heather N. Wahl, J. Rebecca Liu · 2007 · Gynecologic Oncology
  100. Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4
    Yan Xie, Dennis W. Wolff, Taotao Wei, Bo Wang, Caishu Deng, Joseph K. Kirui, Haihong Jiang, Jianbing Qin, Peter W. Abel, Yaping Tu · 2009 · Cancer Research